Differential effects of putative lipoxygenase inhibitors on arachidonic acid metabolism in cell-free and intact cell preparations
Cite this article as: Chang, J., Skowronek, M.D., Cherney, M.L. et al. Inflammation (1984) 8: 143. doi:10.1007/BF00916090 Abstract
The effects of nordihydroguairetic acid (NDGA), 3-amino-1-trifluoromethyl-)-phenyl-2-pyrazoline (BW755c), eicostatetraynoic acid (ETYA), phenidone, quercetin, and indomethacin (INDO) on the synthesis of 15-hydroxyeicosatatetraenoic acid (15-HETE) from soybean 15-lipoxygenase, leukotriene B
4 (LTB 4 from 5-lipoxygenase, and prostaglandin E 2 (PGE 2 from cyclooxygenase enzymes of rat neutrophils and mouse peritoneal macrophages were investigated. All of the drugs caused a dose-related inhibition of increased oxygen consumption by soybean 15-lipoxygenase in the presence of arachidonic acid and the rank order of potency was phenidone ≥ BW755c > ETYA > quercetin > NDGA > indomethacin. The reduction in oxygen consumption correlated with a reduction of 15-HETE formation as identified by high-performance liquid chromatography. Apart from indomethacin, these drugs were also effective against the rat neutrophil 5-lipoxygenase, although the rank order of potency did not correlate with that obtained with soybean 15-lipoxygenase. Furthermore, in both A23187-activated rat neutrophils and zymosan-activated mouse peritoneal macrophages the synthesis of prostaglandins was inhibited by all of these drugs. In the neutrophils, the rank order of potency was INDO > ETYA > BW755c > quercetin > NDGA > phenidone, whereas in mouse peritoneal macrophages, the order was INDO > ETYA > BW755c > NDGA > quercetin > phenidone. These results suggest that putative lipoxygenase inhibitors exhibit both qualitative and quantitative differences in their effects on both lipoxygenases and cyclooxygenases. References
Lewis, R. A.
K. F. Austen
. 1981. Mediation of local homeostasis and inflammation by leukotrienes and their mast cell-dependent compounds.
Samuelsson, B., S. Hammarstrom, R. C. Murphy
. 1980. Leukotrienes and slow reacting substances (SRS-A).
Piper, P. J., M. N. Samhoun, J. R., Tippins, T. J. Williams, M. A. Palmer
M. J. Peck
. 1981. Pharmacological studies on pure SRS-A and synthetic leukotrienes C
. In SRS-A and Leukotrienes. P. J. Piper, editor. Research Studies Press, John Wiley, New York, 81–89.
Drazen, J. M., K. F. Austen
R. A. Lewis
. 1980. Comparative airway and vascular activities of leukotriene C-l and D in vivo and in vitro.
Proc. Natl. Acad. Sci. U.S.A.
Michelassi, F., L. Landa, R. D. Hill, E. Lowenstein, W. D. Watkins, A. J. Petkan
H. M. Zapol
. 1982. Leukotriene D
: A potent cocoronary artery vascoconstrictor associated with impaired ventricular contraction.
Hanna, C. J., M. K. Bach, P. D. Pare
R. R. Schellenberg
. 1981. Slow-reacting substances (leukotrienes) contract human airway and pulmonary vascular smooth muscle in vitro.
Hedqvist, P., S. E. Dahlen, L. Gustafsson, S. Hammarstrom
. 1980. Biological profile of leukotrienes C
Acta Physiol. Scand.
Holroyde, M. D., R. E. Altounyan, M. Cole, M. Dixon
E. V. Elliott
. 1981. Bronchoconstriction produced in man by leukotriene C and D.
Dahlen, S. E., P. Hedqvist, S. Hammarstrom
. 1980. Leukotrienes and potent constrictors of human bronchi.
Morom, Z., J. H. Shelhamer, M. K. Bach, D. R. Morton
. 1982. Slowreacting substances, leukotrienes C
, increase the release of mucus from human airways in vitro.
Am. Rev. Respir. Dis.
Williams, T. J.
P. J. Piper
. 1980. The action of chemically pure SRS-A on the microcirculation in vivo.
Dahlen, S. E., J. Bjork, P. Hedqvist, K. E. Arfors, S. Hammarstrom, J. A. Lindgren
. 1981. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: In vivo effects with relevance to the acute inflammatory response.
Proc. Natl. Acad. Sci. U.S.A.
Ford-Hutchinson, A. W., M. A. Bray, M. V. Doig, M. E. Shipley
M. J. H. Smith
, 1980. Leukotriene B
, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes.
Goetzl, E. J., A. R. Brash, A. J. Tauber, J. A. Oates
W. C. Hubbard
, 1980. Modulation of human neutrophil function by monohydroxy-eicosatetraenoic acids.
Stenson, W. F.
C. W. Parker
, 1980. Monohydroxyeicosatetraenoic acids (HETEs) induce degranulation of human neutrophils.
Klickstein, L. B., Shapleigh, C.
Goetzl, E. J.
, 1980. Lipoxygenation of arachidonic acid as a source of polymorphonuclear leukocyte chemotactic factors in synovial fluid and tissue in rheumatoid arthritis and spondyloarthritis.
J. Clin. Invest.
Yen, S. S.
H. G. Morris
, 1981. An imbalance in arachidonic acid metabolism in asthma.
Biochem. Biophys. Res. Commun.
, 1976. On the formation of thromboxane B
and 12L-hydroxy-5, 8, 10, 14-eicostetraenoic acid (12–20:4) in tissues from the guinea pig.
Biochim. Biophys. Acta
Armour, C. L., J. M. Hughes, J. P. Seale
D. M. Temple
, 1981. Effect of lipoxygenase inhibitors on release of slow-reacting substances from human lung.
Eur. J. Pharmacol.
D. J. Osborne
. 1983. A rapid method for detecting inhibitors of both cyclooxygenase and lipoxygenase metabolites of arachidonic acid.
J. Pharmacol. Methods
Higgs, G. A., R. J. Flower
J. R. Vane
. 1979. A new approach to antiinflammatory drugs.
Radmark, O., C. Malmsten
. 1980. The inhibitory effects BW755c on arachidonic acid metabolism in human polymorphonuclear leukocytes.
. 1974. Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets.
Proc. Natl. Acad. Sci. U.S.A.
Blackwell, G. J.
R. J. Flower
. 1978. 1-Phenyl-3-pyrazolidone: An inhibitor of cyclicoxygenase and lipoxygenase pathways in lung and platelets.
Hope, W. C., A. F. Welton, C. F. Nagy, C. B. Bernardo
J. W. Coffey
. 1983. In vitro inhibition of the biosynthesis of slow reacting substance of anaphylaxis (SRS-A) and lipoxygenase activity by quercetin.
Baumann, J., F. V. Bruchhausan
. 1980. Flavanoids and related compounds as inhibitors of arachidonic acid peroxidation.
. 1982. The influence and some 3-amino-2-pyrazoline derivatives on cyclooxygenase and lipoxidase activities.
Knippel, I., J. Baumann, F. Bruchhausen
. 1981. Interactions of sulfhydryl agents and soybean lipoxygenase inhibitors.
Flower, R. J.
1974. Drugs which inhibit prostaglandin biosynthesis.
Vanderhoek, J. Y., R. W. Bryant
J. M. Bailey
. 1980. Inhibition of leukotriene biosynthesis by the leukocyte product, 15-hydroxy-5, 8, 11, 13-eicosatetraenoic acid.
J. Biol. Chem.
E. L. Becker
. 1983. Inhibition of neutrophil phospholipase A
by bromophenylaculbromide (BPB), nordihydroguiaretic acid (NDGA), eicosatetraenoic acid (ETYA) and quercetin.
Google Scholar Copyright information
© Plenum Publishing Corporation 1984